PHC 102

Drug Profile

PHC 102

Alternative Names: 99mTc-CAIX; PHC-102

Latest Information Update: 28 Feb 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Philochem
  • Class Radiopharmaceutical diagnostics; Small molecules; Technetium compounds
  • Mechanism of Action Diagnostic imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Prostate cancer; Renal cell carcinoma

Most Recent Events

  • 27 Feb 2017 Philochem plans a phase I trial for diagnosis of Renal cell carcinoma (Philochem pipeline, February 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top